ViaDerma Transdermal Delivery Solutions
ViaDerma, Inc. is a specialty pharmaceutical company committed to bringing the best new products to market through many years of innovative clinical research, testing & product development. ViaDerma licenses products in the fields of medicine ranging from infectious diseases to wound care, skin care, CBD, cosmetics, and more. In addition to licensing our proprietary transdermal technologies, our lead product Vitastem is available for treating multiple skin conditions & ailments.

Acne Treatments
$10.03 Billion in 2022

Anti-Aging Cosmetics
$67.5 Billion in 2022

Eczema Treatments
$11.77 Billion in 2022

Psoriasis Treatments
$27.36 Billion in 2022

Skin Cancer Treatments
$3.06 Billion in 2022

Medical Cannabis
$13.8 Billion in 2022

Diabetic Amputations
$4.98 Billion in 2022

Finger & Toenail Fungus
$4.44 Billion in 2022

Burn Treatments
$2.3 Billion in 2022
Topical Antibiotics
$137.15 Billion in 2022
Male Pattern Baldness
$8.81 Billion in 2022
Pain Management
$75.41 Billion in 2022